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Here we investigate the roles of the Bone Morphogenetic Protein (BMP) antagonists Chordin and Noggin in development of
the mandible, which is derived from the first branchial arch (BA1). Both genes are expressed in the pharynx during early
mandibular outgrowth and later in the mandibular process. Mice mutant for either Nog or Chd have only mild mandibular
defects; however, pups of the genotype Chd2/2;Nog1/2 exhibit a range of mandibular truncation phenotypes, from normal to
agnathia. A few embryos homozygous null for both genes survive to late gestation; many are agnathic, though a few have
significant mandibular outgrowth. In mandibular explants, ectopic BMP4 rapidly induces expression of both Chd and Nog,
consistent with results obtained in vivo with mutant embryos. Previous work has shown that FGF8 is a survival factor for
cells populating the mandibular bud. We find that excess BMP4 represses Fgf8 transcription in mandibular explants.
Embryos lacking these BMP antagonists often show a strong reduction in Fgf8 expression in the pharyngeal ectoderm, and
increased cell death in the mandibular bud. We suggest that the variable mandibular hypoplasia in double mutants involves
increased BMP activity downregulating Fgf8 expression in the pharynx, decreasing cell survival during mandibular
outgrowth. © 2001 Elsevier Science
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The first branchial arch gives rise to many components of
the vertebrate skull, including the jaws, teeth and numer-
ous bones of the skull. In mice, BA1 begins at approxi-
mately embryonic day (E) 8.5 as a swelling on either side of
the future oral cavity, forming the maxillary and mandibu-
lar prominences; these develop into the maxilla and man-
dible (the upper and lower jaw, respectively). These out-
growths of BA1 grow ventrally towards the midline and fuse
at approximately E9.0. Their development is bilaterally
symmetric, but the two halves are formed and patterned
independently prior to fusion along the midline. Each arch
is primarily populated by neural crest (NC) cells originating
from the interface of surface and neural ectoderm at the
dorsal neural tube (Le Douarain, 1982; Chai et al., 2000). For
proper BA1 development to occur, these cells must properly
proliferate and migrate into the branchial arches.
Mandibular development has three major components.
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All rights reserved.The first is outgrowth, by which the mandibular promi-
nence grows distally from the embryo, as described above.
Odontogenesis is the process by which tooth fields are
specified and develop into mature dental structures (re-
viewed in Thesleff and Sharpe, 1997; Jernvall and Thesleff,
2000). Meanwhile, skeletal development results in forma-
tion of the supporting structures of the lower jaw.
Expression data and ectopic application of recombinant
protein have suggested that BMPs have important roles in
all three phases of BA1 development (Neubuser et al., 1997;
Bei and Maas, 1998; Dassule and McMahon, 1998; Jernvall
et al., 1998; Zhang et al., 2000). Application of BMP4
protein both in vivo and in vitro results in decreased
mandibular outgrowth in the chicken, perhaps as a result of
increased cell death (Ekanayake and Hall, 1997; Shigetani et
al., 2000). However, mice mutant for both Bmp5 and Bmp7
show decreased head and branchial arch mesenchyme, also
possibly due to cell death (Solloway and Robertson, 1999).
These and other data show that mandibular development is
very sensitive to the level of BMP signaling during the
initial outgrowth phase. During odontogenesis, BMPs can
mimic the inductive properties of the dental epithelium on
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shape tooth identity in vitro (Tucker et al., 1998). Several
studies implicate BMPs in patterning the skeletal elements
of the mandible, in that ectopic BMP will promote growth
of ectopic mandibular bones (Barlow and Francis-West,
1997; Wang et al., 1999; Semba et al., 2000).
The actual requirements for BMPs in mandibular devel-
opment are unclear. Their roles are obscured both by their
requirements in early development (Winnier et al., 1995;
Zhang and Bradley, 1996), and by functional redundancy
(e.g., Solloway and Robertson, 1999). However, BMP2 is
required for formation of migratory cranial NC, including
that which populates BA1 (Kanzler et al., 2000). The puta-
tive BMP4 targets Msx1 and Msx2 are required for develop-
ment of teeth as well as other craniofacial structures
(Satokata and Maas, 1994; Satokata et al., 2000). Although
the requirements of Msx genes for craniofacial development
are consistent with an essential role for BMP signaling,
other factors, such as FGFs, also positively regulate Msx1 in
facial primordia (Bei and Maas, 1998; Kettunen and
Thesleff, 1998).
Signaling by BMPs is tightly regulated by various down-
stream effectors and inhibitors as well as by extracellular
antagonists (for review see Massague and Chen, 2000). Two
of the known BMP antagonists are Chordin and Noggin.
These are structurally unrelated proteins, both of which
bind BMPs in the extracellular space to prevent activation
of BMP receptors (Piccolo et al., 1996; Zimmerman et al.,
1996). Based on their expression in the Xenopus Spemann’s
organizer and their activity in embryological assays, Chor-
din and Noggin were identified as candidate molecules for
the neural inductive properties of the organizer (Smith and
Harland 1992; Sasai et al., 1994).
Null mutations in Chordin (Chd) and Noggin (Nog) reveal
that they are not required for neural induction, neither
individually nor together, although they are essential for
many later developmental events (Brunet et al., 1998;
McMahon et al., 1998; Bachiller et al., 2000). A lack of Nog
function is lethal at birth and results in profound defects of
the skeleton, as well as severe neural tube defects (Brunet et
al., 1998; McMahon et al., 1998). Homozygosity for a Chd
null allele is viable with minor defects in the axial skeleton
in a random outbred genetic background (D. Bachiller and
J. K., unpublished results). In defined genetic backgrounds,
however, Chd nullizygosity is perinatal lethal with defects
primarily in branchial arch derivatives (Bachiller et al.,
2000; Bachiller et al., unpublished results; R.M.A. and J.K.,
unpublished results).
We have begun a genetic analysis of the requirement for
the BMP antagonist genes Chd and Nog in craniofacial
development. In this study, we confine our analysis to the
role of these genes in early mandibular development. We
find that although Nog has a unique role in mandibular
skeletal morphogenesis, Chd and Nog function in a redun-
dant fashion for mandibular outgrowth. Based on the
premise that BMP activity increases when these antago-
nists are decreased, we have employed a mandibular ex-
© 2001 Elsevier Science. Aplant culture system to model the effects of increased BMP
activity present in mutant BA1. We use this explant system
to probe regulatory interactions involving BMP signaling
and test these in vitro findings in the mouse mutants. We
find that BMPs are capable of affecting the transcription of
FGF8 targets, Fgf8 itself, and, surprisingly, of BMP antago-
nists. Based on our analysis of Chd;Nog double mutants, we
suggest that mandibular development requires proper
modulation of BMP activity, and that mandibular hypopla-
sia in the mutants involves variable downregulation of Fgf8
expression.
MATERIALS AND METHODS
Embryo Collection
Nog2/2 mutants were obtained by crossing Nog9E/1 (a LacZ
insertion at the noggin locus; McMahon et al., 1998) mice inter se.
Noggin mutant mice are maintained in 129Sv, C57Bl6, and random
outbred backgrounds (Nog genotyping done by phenotype and PCR;
McMahon et al., 1998) while Chd;Nog compound mutants are in a
random outbred background. ICR mice (Harlan) were used for
random outbreeding and for wildtype embryos in explant and in
situ analysis. Chordin genotyping and the ChdRV allele are de-
scribed in Bachiller et al. (2000). Chordin mutant mice are main-
tained in a 129Sv inbred background. Wild type embryos for
explant culture were obtained from timed matings of ICR mice; a
copulation plug at noon was noted as embryonic day 0.5.
Organ Culture and Bead Implantation
Mandibular cultures were prepared as described (Vainio et al.,
1993) with some modifications (a detailed protocol is available on
request). Explants were usually cultured with the oral side on
membrane culture inserts (Whatman) with beads on the aboral
surface. Beads were prepared as described (Vainio et al., 1993).
Recombinant BMP4 was obtained from Genetics Institute (Cam-
bridge, MA; 80 ng/ml on Affigel beads). Control beads were treated
with PBS or 0.1% BSA in protein storage buffer. Culture medium
used is DMEM (Gibco), 10mM nonessential amino acids (Gibco),
0.1 mM b-mercaptoethanol (Gibco), Pen-Strep, and 15% FCS
(HyClone). Explants classified as E10.5 were taken from embryos at
30–35 somites. E11.5 embryos were at 35–40 somites.
In Situ Hybridization and Probes
Whole mount in situ hybridization was similar to that of Belo et
al. (1997). All probes used in this study are published: AP2a
(Mitchell et al., 1991), Bmp4 (Winnier et al., 1995), Chordin
(Klingensmith et al., 1999), Fgf8 (Crossley and Martin, 1995), Msx1
(Mackenzie et al., 1991), Noggin (McMahon et al., 1998), and Pax9
(Neubuser et al., 1995).
RT-PCR
Chordin expression was documented using total RNA from
stage-appropriate embryos isolated using standard RNA purifica-
tion techniques (Stratagene total RNA isolation kit). Total RNA
was used for in vitro cDNA synthesis with MMLV reverse tran-
scriptase (MMLV-RT; Gibco). HPRT was amplified as a control for
ll rights reserved.
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ing primers: (CCTGCTGGATTACATTAAAGCACTG) and (GT-
CAAGGGCATATCCAACAACAAAC). Chd was amplified with
ChdRT1 (CCAGAGCATCGCAGTTACAG) and ChdRT2 (TGT-
GGGATCTGTGAAACGAA).
Cell Death, Proliferation, and Histology
Cell death was detected as described; briefly, in whole embryos
by staining with nile blue sulfate (Sigma N-5632; Bowen and
Lockshin, 1981) or in sectioned material by TUNEL (Roche;
manufacturer’s protocol). Proliferation was assayed in sections by
labeling with anti-phosphohistone H3 (Upstate Biochemicals) as
described (Hentges et al., 1999). To determine the expression of
noggin in sectioned material, embryos heterozygous for the noggin-
LacZ allele were cryo-sectioned and stained with X-gal using
standard methods (Hogan et al., 1994).
RESULTS
BMP Antagonists Are Expressed in the Developing
First Branchial Arch
To begin determining a potential role for BMP antago-
nists in mandibular development, we have studied the
expression of noggin and chordin in early BA1 develop-
ment. Of interest were expression domains in the mandib-
ular prominence itself, in the NC that migrates into the
arch, and in the pharynx, through which the NC cells
migrate enroute to the bud. Noggin expression was ana-
lyzed both by b-galactosidase staining of embryos carrying a
lacZ integration in the Nog locus (see Materials and Meth-
ods) and by whole mount in situ hybridization (WMISH).
Nog-lacZ embryos show expression in the mesenchyme of
the initial swelling of BA1 (E8.5; Fig. 1A) in a pattern
suggestive of migrating NC, which populates the mesen-
chyme of BA1 (e.g., Chai et al., 2000). Noggin has previ-
ously been shown to be expressed in chicken migrating NC
cells (Smith and Graham, 2001). Noggin is expressed in the
mesendoderm derived from the node through at least E8.5,
including the roof of the pharynx (R.M.A., unpublished
results). As the mandibular prominence extends during
E9.0–9.5, expression is also seen in the pharyngeal/caudal
mandibular ectoderm (Fig. 1B). These expression domains
are recapitulated with WMISH of E9.5 embryos (Fig. 1C). At
E10.5 (Fig. 1D) and E11.5 (Fig. 1F), Nog expression is seen by
WMISH in the oral epithelium of the mandible. Sense
riboprobe controls show no epithelial signal (Fig. 1E).
b-galactosidase staining of cryo-sectioned Nog1/2 embryos
at E10.5 (Fig. 1G) confirm this low-level ectodermal expres-
sion. Cryo-sections also show a domain of high expression
in the deep mesenchyme, possibly in precursors of Meckel’s
cartilage (Fig. 1H), which is derived from NC cells. Nog
expression in Meckel’s cartilage is high at later stages (data
not shown). Although Nog is expressed in the NC emigrat-
ing to BA1, it is not clear if the expression in Meckel’s
cartilage is a direct continuation of NC expression or a
separate inductive event. Mesenchymal expression is, how-
© 2001 Elsevier Science. Aever, distinct from the epithelial expression seen at later
stages as the epithelium and mesenchyme do not exhibit
significant mixing during BA1 development (Chai et al.,
2000). Our analysis focused on expression in the mandibu-
lar prominence, but we also noted expression in the maxil-
lary prominence (data not shown).
Other work has demonstrated weak Chd expression in
the branchial arches at E10.5 and E11.5, assayed by section
in situ hybridization using radioactive probes (Scott et al.,
2000). Expression appeared to occur at low levels through-
out the arch. To further define when and where Chd is
expressed, especially relative to Nog, we used digoxigenin-
labeled riboprobes in WMISH experiments. At E8.5, as the
mandibular bud emerges, a low-level of expression was
observed in the pharyngeal and mandibular bud ectoderm,
and in the forming pharyngeal cleft (Fig. 2A). At this time,
Chd is also expressed in the roof of the foregut, that is, in
dorsal pharyngeal endoderm (R.M.A., unpublished results).
At E9.0 weak pharyngeal ectoderm expression was ob-
served, with probable weak expression in the pharyngeal
endoderm as well (Fig. 2B). We also observe low-level Chd
expression in BA1 at E10.5 (Fig. 2E,F) and E11.5 (Fig. 2G,H).
Expression at E9.5 is much less distinct (Fig. 2C,D). Expres-
sion in mandibular processes appears to be predominantly
ectodermal (data not shown). Because none of these do-
mains of Chd expression was strong as visualized by
WMISH, we performed RT-PCR analysis to assess indepen-
dently the expression of Chd in these tissues. We detected
Chd expression at each stage of BA1 development exam-
ined: in E8.5 pharyngeal tissue and in mandibular processes
at E9.5-E11.5 (Fig. 2I).
These results indicate that both Noggin and Chordin are
expressed such that they might have a role in the three
major phases of BA1 development. Their expression in and
around the pharynx as the mandibular bud emerges would
be consistent with a role in outgrowth. Later expression in
the mandibular ectoderm through at least E11.5 could
enable them to function during early odontogenesis
(Thesleff and Sharpe, 1997). Noggin at least seems also to be
potentially involved in early skeletogenesis, based on its
expression in Meckle’s cartilage. Because Chordin and
Noggin appear to act exclusively by antagonizing BMPs
such that BMP signal transduction is precluded (Harland
and Gerhart, 1997), these expression domains of Chd and
Nog would be relevant only if BMPs were expressed nearby.
Indeed, those BMPs known to be antagonized by Chordin
and Noggin (BMP2, 4 and 7) are each expressed during all
three phases of BA1 development in tissues overlapping or
near Chd and Nog expression (Begbie et al., 1999; Jones et
al., 1991;Kanzler et al., 2000; Lyons et al., 1990; Solloway
and Robertson, 1999). BmprIA, encoding a receptor for
BMP2, BMP4, and perhaps other family members (Mas-
sague and Chen, 2000), is expressed ubiquitously through-
out the embryo at these stages (DeWulf et al., 1995;
Panchison et al., 2001).
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on Mandibular Development
We have analyzed mice homozygous null for either Chd
or Nog for defects in mandibular development. The overall
phenotype of both mutations depends on the genetic back-
ground in which the null allele is carried. We examined
Nog2/2 mutants in a highly polymorphic, outbred back-
ground and in two inbred backgrounds, C57bl6 and 129Sv.
The phenotypes at birth are very similar in each case;
however, the craniofacial phenotype is more severe in the
129Sv background, which is presented here. When com-
pared at birth to wild-type 129Sv mice (Fig. 3A,D), Nog2/2
littermates (Fig. 3B,E) have an incompletely penetrant phe-
notype of micrognathia, among other more drastic defects
FIG. 1. Expression of noggin in the developing first branchial
arch. The expression of Nog was determined using both a LacZ
insertion (A, B, G, H) as well as whole mount in situ hybridization
of isolated BA1 (first branchial arch) with Nog probe (C, D, F).
Nog-lacZ expression faithfully represents the spatiotemporal pat-
tern of Nog transcription (McMahon et al., 1998). X-gal staining at
E8.5 (A) and E9.5 (B) shows expression of Nog in a punctate pattern
suggestive of migrating NC cells, which populate the mesenchyme
of BA1 (Trainor and Tam, 1995; Imai et al., 1996). This is also seen
in WMISH (C). Expression of Nog-lacZ is also indicated at the
dorsal neural tube in a rhombomere-specific pattern where these
NC cells are initiating (arrowheads in B). At E10.5 (D, E, G) and
E11.5 (F, H), Nog expression is seen at low levels in the oral
epithelium. Sense controls (E) show no expression. Sagittal cryo-
sections at E10.5 (G) and E11.5 (H) show individual cells (arrows)
expressing the Nog-lacZ reporter in the oral epithelium. At E10.5,
expression is also seen in Meckel’s cartilage (MC; black arrow).of skull development. All mutant mice in each genetic
© 2001 Elsevier Science. Abackground observed, however, exhibit a mildly malformed
mandible characterized by increased bone thickness (Fig.
3E,K). C57bl6 Nog2/2 mutants were not analyzed for out-
growth phenotypes as they have a variably penetrant reduc-
tion in total head size.
In an inbred 129Sv background, mice homozygous null
for Chd are born dead and have a variety of facial defects,
externally characterized by a reduced distance between the
eye and pinna (Fig. 3C). Defective skeletal elements include
BA1 derivatives such as the zygomatic and temporal bones,
as well as bones of the chondrocranium (data not shown). A
similar phenotype is observed in a defined hybrid back-
ground, and we present a mechanistic analysis of these and
FIG. 2. Expression of chordin in the developing first branchial
arch. Expression of chordin by WMISH is seen at E8.5 (A) in the
pharyngeal endoderm (arrow). At E9.0 (B), expression is seen in both
pharyngeal endoderm and ectoderm. At E9.5 (C), low levels of Chd
expression are seen in BA1 and become stronger at E10.5 (E) and
E11.5 (G). Sense riboprobe controls at each age (D, F, H) show no
appreciable signal. Chd expression was also addressed using RT-
PCR (I), since in situ expression was weak. Pharyngeal regions of
E8.5 embryos (ln. 2) as well as branchial arches from E9.5 (ln. 3),
E10.5 (ln. 7) and E11.5 (ln. 8) show Chd transcripts. Other embry-
onic regions with low levels of Chd expression as assayed by
WMISH, such as the allantois (data not shown), show Chd expres-
sion with RT-PCR (ln. 4). Control reverse transcription reactions of
blank samples (ln. 5), without MMLV-RT (ln. 6), and water PCR
controls (ln. 9) show no PCR products. (a: allantois, h: heart, mbl:
left midbrain, mbr: right midbrain, ov: optic vesicle, p: pharynx)
ll rights reserved.
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461Chordin and Noggin in Mandibular Outgrowthother Chd2/2 phenotypes elsewhere (D. Bachiller, R.M.A,
J.K, unpublished results). However, in all cases to date,
regardless of genetic background, Chd2/2 pups have overtly
normal mandibles (Fig. 3F,I,L). Although the mutant man-
dibles occasionally appeared to be smaller than those from
their wildtype littermates, this seemed to be part of a
modest microcephaly phenotype, in which all skeletal
elements of the head were often slightly smaller than in
wildtype (data not shown).
Our analysis makes clear that the BMP antagonists Chor-
din and Noggin are individually necessary for normal de-
velopment of BA1 derivatives. However, despite expression
in the oral epithelium, we detected no mandibular defects
in the absence of Chd. The thickened mandible phenotype
FIG. 3. Loss of noggin or chordin have mild effects on mandibu
prepared to highlight bone and cartilage (D-F) reveal craniofacial d
background, Nog2/2 mice are largely missing the calvaria (anence
backgrounds they are usually intact (data not shown). Chd2/2 mice
between the eye (e) and pinna (p). The defective skeletal element
(asterisks in D, F indicate defects in temporal bone formation; R.
single mutant are shown orally (G, H and I) and laterally (J, K an
incompletely penetrant micrognathia, but are always characterized
(J) or Chd2/2 mutants (L). Chd2/2 mutants have mandibles which re
(double arrowheads in J, K and L; 14:16 in Nog2/2, 6:6 in Chd2/2). Alv
normal in both Nog2/2 and Chd2/2 mutants. Scale bar represents 1of Nog2/2 pups is consistent with previously observed
© 2001 Elsevier Science. Askeletal defects in other bones of Nog2/2 mutants (Brunet et
al., 1998), and thus may reflect a more general role for
Noggin in skeletal development. Mechanistic analysis of
the mandible skeletal dysmorphology is beyond the scope
of this paper.
Although BMPs have been implicated in proper tooth
patterning and development (Tucker et al., 1998), a prelimi-
nary analysis revealed no significant tooth phenotype in
either Chd or Nog homozygotes. Skeletal preparations
clearly show the presence of incisors and alveolar ridges
(site of molar development) in both classes of mutants (Fig.
3G-L). Because Nog mutants display a mandibular pheno-
type, we cryo-sectioned mandibles of Nog2/2 mutants at
both P0 and E14 to address early tooth development. We
velopment. Examination of whole perinatal pups (A-C) and pups
s in Nog2/2 (B, E) when compared to wild type (A, D). In the129Sv
; B, E; double-lined arrow), while in the outbred and C57 inbred
how craniofacial defects (C, F) characterized by a reduced distance
lude BA1 derivatives, such as the zygomatic and temporal bones
., unpublished results). Isolated mandibles for wild-type and each
to highlight skeletal abnormalities. Nog2/2 mutants (H, K) show
thickened mandible (arrowheads in K) when compared to wild type
overtly normal (F, I, L). Incisors are present in both mutant classes
ridges (AR: skeletal structures surrounding the molars) also appear
in G, H, I and 1.6 mm in J, K, L.lar de
efect
phaly
also s
s inc
M. A
d L)
by a
mainfound that both maxillary and mandibular molars are
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462 Stottmann, Anderson, and Klingensmithpresent at birth and seem to be patterned correctly (data not
shown).
Chd;Nog Double Mutants Have a Spectrum
of Mandibular Hypoplasia
Chordin and Noggin are coexpressed in the mandibular
prominence and are dedicated antagonists of the same
BMPs (Harland and Gerhart, 1997), and homozygotes for
null alleles of either gene exhibit only mild mandibular
phenotypes at worst. To test the possibility of functional
redundancy in mandibular development, we generated
double mutants lacking both Chd and Nog. This genotype
(Chd2/2;Nog2/2) is hereafter referred to as the double null
mutant. Double mutants were generated in an outbred
genetic background, since mandibular phenotypes do not
change as a result of genetic background (see above). This
allowed us to exploit the increased fecundity of outbred
mice and the viability of Chd homozygosity in an outbred
background, thus making the production of double mutants
much more efficient.
While generating the double null mutants, we observed a
severe mandibular phenotype in mice lacking both copies of
Chd and one copy of Nog (Chd2/2;Nog1/2). We will refer to
this genotype as the complex heterozygote. We found that
about 10% of complex heterozygotes display conspicuous
anterior tissue deficits but no apparent phenotypes poste-
rior to the neck; many of these displayed jaw truncations
that occurred independently of more rostral defects
(R.M.A., unpublished results). We found an overall fre-
quency of mandibular truncations of about 9% in complex
heterozygotes, but did not observe such defects in Chd or
Nog hetero- or homozygotes (Table 1). We analyzed these
perinatal-lethal complex heterozygote pups for mandibular
defects, observing a variety of phenotypes ranging from
normal (Fig. 4A,B) to mild micrognathia (Fig. 4C,D) and
occasional agnathia (Fig. 4 E,F). Additionally, some mutants
show mandibular defects that are bilaterally asymmetric;
for example, resulting in one normal half-mandible and one
completely absent (Fig. 4G,H). In the example shown here,
the unaffected side even has an incisor indicating proper
mandibular patterning all the way to the distal extremities.
While some complex heterozygotes show abnormal odon-
togenesis, these defects result from loss of distal mandibu-
lar tissue rather than specific problems in tooth patterning.
In complex heterozygotes having overtly normal man-
dibles, regardless of the severity of more rostral defects, we
did not observe tooth defects (data not shown).
Double null mutants (Chd2/2;Nog2/2) show defective pat-
terning of the anterior–posterior, dorsal–ventral and left-
right axes, but rarely survive past E10.5 (Bachiller et al.,
2000). Our initial analysis showed that those Chd2/2;Nog2/2
embryos surviving through branchial arch stages exhibit
agnathia (Bachiller et al., 2000). These double mutants were
analyzed in a mixed hybrid genetic background; the double
null mutants studied here are in an outbred background,
but display defects in all three axes indistinguishable from
© 2001 Elsevier Science. Athose of the mixed hybrid background (R.M.A. and J.K.,
unpublished results). However, at least in the outbred
background, there is a range of mandibular phenotypes in
the double null mutant. In some cases, despite severe
rostral defects, BA1 formation is surprisingly normal de-
spite the complete absence of Chd and Nog (Fig. 4J). Other
embryos displaying similar anterior defects show greatly
reduced BA1tissues (Fig. 4K); these presumably would re-
flect the agnathic embryos that occasionally survive to late
gestation.
In sum, our analysis of Chd;Nog complex heterozygotes
and double null mutants revealed a range of mandibular
phenotypes within both genotypic classes. All of the phe-
notypes described above in the two classes of double mu-
tant appear to be due to defects in mandibular outgrowth,
since they are detectable well before the onset of skeleto-
genesis. The severity of the mandibular deficit is typically
greater in the double mutant than in the complex hetero-
zygote, though either genotype can display mildly micro-
gnathic through agnathic phenotypes. These results indi-
cate a partial functional redundancy between the BMP
antagonists Chordin and Noggin in BA1 development. The
phenotypic variability also indicates mandibular develop-
ment is variably sensitive to the levels of BMP antagonists
and, presumably, of BMP activity.
An Explant System to Assay the Effects of
Increased BMP Signaling in the Developing
Mandibular Prominence
Mechanistic analysis of the BA1 defects in Chd;Nog
mutants proves very difficult because complex heterozy-
gote mandibular phenotypes are rare and vary in severity
(i.e., exhibit low penetrance and variable expressivity), and
TABLE 1
Nog and Chd Mandibular Outgrowth Phenotypes
Nog1/2 no outgrowth phenotypes in .100 adults
Chd1/2 no outgrowth phenotypes in .100 adults
Nog2/2 no outgrowth phenotypes in .35 P0 pups
Chd2/2 no outgrowth phenotypes in .35 P0 pups
Chd2/2;Nog1/2
(n 5 98 P0
animals)
Agnathic Micrognathic
Asymmetrical
Defect
4 2 2
Chd2/2;Nog2/2
(n 5 23 viable
embryos from
E9.5–E11.5)
Severe Moderate Asymmetric None
7 11 2 3
Note. Animals of each genotype were observed for defects in
mandibular outgrowth. Skeletal preparations of P0 pups were
examined after processing and adults were observed during hus-
bandry. Double homozygosity is lethal at midgestation, preventing
analysis of perinatal jaw phenotypes.the double null embryos usually die by E10.5. Due to the
ll rights reserved.
463Chordin and Noggin in Mandibular Outgrowthbiochemical function of Chordin and Noggin, we suspect
the defects described above are the result of an overactive
BMP signaling cascade. To more fully explore the possible
effects of enhanced BMP signaling in the mandibular arch,
we have employed a well-established mandibular explant
system (reviewed by Slavkin et al., 2000). In this technique
(Fig. 5A), recombinant proteins can be applied to the ex-
plants and molecular consequences analyzed through in
situ hybridization.
We have chosen to culture mandibular portions of BA1
explants and applied a bead incubated in recombinant
protein or in control carrier buffer on one side of the
explant, that is on one “half-arch,” (see Fig. 5A). While gene
expression domains may shift slightly in some explants
from in vivo due to flattening of the explanted tissue during
culture, it remains very obvious when the BMP beads have
affected a molecular change. Culturing the explants with-
out splitting them in half, a common manipulation used in
mandibular culture, gives us an internal control after visu-
alizing gene expression: the control side of each explant
should indicate endogenous gene expression and be used as
a comparison to treated tissue.
To mimic the increased BMP signaling that may be
occurring in the various Chd and Nog mutant embryos, we
have added sepharose beads treated with recombinant
BMP4 protein to the explant epithelium. These beads
should act to increase the level of activation of the BMP
signal transduction pathway in the epithelium. We have
assayed the effects of recombinant protein by using whole
mount in situ hybridization to reveal the expression of
possible BMP targets (see Table 2 and representative ex-
amples shown in Fig. 5B-J). As previously demonstrated
(Vainio et al., 1993), ectopic BMP4 induces the putative
target transcription factor, Msx1 (Fig. 5B). Similarly, as
shown before (Neubuser et al., 1997), ectopic BMP4 inhibits
the transcription of the putative Fgf8 target, Pax9 (Fig. 5E).
These experiments confirm that this mandibular explant
system can be used to model what may be occurring in
mandibular prominences with reduced levels of BMP an-
tagonism, as is presumably the case in Chd;Nog mutants.
Ectopic BMP4 Represses Fgf8 Expression in Mouse
Mandibular Cultures
Two separate pieces of evidence led us to test for effects
of increased BMP4 on the expression of Fgf8 itself. First, the
phenotypes we observe in the complex heterozygote are
similar in severe cases to the phenotypes of mouse embryos
specifically lacking Fgf8 expression in BA1 (i.e., agnathia;
Trumpp et al., 1999). Moreover, the BMP and FGF signaling
pathways are known to interact antagonistically in many
developmental contexts, including development of branchial
arches, where they act to restrict the expression of Pax9,
Pitx2, and Barx1 to precise locations on the proximal–distal
axis of the branchial arch (Neubuser et al., 1997; Barlow et al.,
1999; St. Amand et al., 2000). We observe that ectopic BMP4
inhibits transcription of Fgf8 (Fig. 5H) in addition to the Fgf8
© 2001 Elsevier Science. Atarget gene Pax9 (Fig. 5E) in mouse mandibular cultures (Table
2). The effects of ectopic BMP4 were replicable independent of
bead position on the explant in the medial-lateral or anterio-
posterior axes (data not shown).
Ectopic BMP4 Induces the Expression of Its Own
Antagonists in BA1 Cultures
Previous experiments in cell culture models (Gazzerro et
al., 1998; Kameda et al., 1999; Nifuji and Noda, 1999) and in
chicken limb digits (Merino et al., 1998) suggest that Nog
may be directly regulated by BMP4. We find this is also true
in our culture system (Table 2); ectopic BMP4 induced the
expression of Nog (Fig. 5D). We find that BMP4 can also
induce the expression of Chd in mandibular explants (Table
2), albeit at relatively low levels (Fig. 5G). This induction
is more robust in explants prepared from E11.5 embryos
(Fig. 5J).
Noggin Is Induced Rapidly Upon Increased BMP4
Signaling, While Fgf8 Repression Is Slower
To further address the mechanism of Fgf8 repression and
Nog induction, we looked at the effects of ectopic BMP4 at
1, 3, and 6 h of culture (see Table 3). We find that Msx1 and
Nog are both induced within 1 h of BMP4 application (Fig.
6 A,C). Fgf8 expression does not appear to be reduced until
3 h of BMP4 co-culture (Fig. 6F). These data indicate that
increased BMP activity rapidly induces its own antagonist,
probably via molecular mechanisms already present in the
cell rather than by increased transcription of BMP effectors
such as Msx1. In contrast, Fgf8 repression may be less
direct.
Mice Lacking BMP Antagonist Genes Exhibit
Elevated BMP Signaling and Reduced Fgf8
Expression
Results from the mandibular explant assays suggest that
some molecules known to be involved in patterning BA1
may be misexpressed in mice lacking proper BMP antago-
nism. Specifically, one might expect expanded expression
domains of genes induced by BMP4, and smaller domains
for genes induced by Fgf8. Our explant analysis revealed the
ability of BMP4 to induce Nog, so we assessed Nog2/2
embryos for expression of the Nog-lacZ reporter. Nog2/2
embryos expressed much higher levels of lacZ than did
heterozygous littermates, and Chd2/2;Nog2/2 embryos ex-
pressed Nog-lacZ at even higher levels (compare Fig. 7A, B,
and C). This increase in Nog-lacZ expression was broadly
present, including BA1 (compare Fig. 7D and E). Increased
levels of Nog-lacZ expression are not simply due to lacZ
copy number, because WMISH at E9.5 also shows increased
expression in Nog2/2 embryos (Fig. 7G) compared to unaf-
fected littermates (Fig. 7F), especially in the neural tube.
Expression of Nog in the NC at this stage is also increased
in the Nog2/2 embryos (Fig. 7B,C). Assuming that more
ll rights reserved.
unaffected BA1 (J) to clearly dysmorphic (K). All arrowheads
indicate BA1.
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© 2001 Elsevier Science. ABMP activity results from the loss of these BMP antago-
nists, our results would imply that BMPs induce their own
antagonists in vivo as well as in vitro.
Consistent with results showing the ability of BMP4 to
induce its own expression in the dental mesenchyme and
other tissues (Vainio et al., 1993; McMahon et al., 1998),
the expression of Bmp4 is slightly increased in BA1 of
Nog2/2 embryos when compared to unaffected littermates
(Fig. 7H,I; 2:2). The signal appears both stronger and slightly
expanded in mutants.
The role of Fgf8 in BA1 development has been revealed by
recent data from a branchial arch specific knockout
(Trumpp et al., 1999). Mandibles in these mice showed a
range of phenotypes similar to those seen in our mutants.
Since we observed that surplus BMP4 represses Fgf8 expres-
sion in mandibular explants, we speculated that the af-
fected Chd;Nog mutants might exhibit reduced Fgf8,
whereas unaffected embryos of the same genotype would
not. Because BMP can upregulate its own antagonists and
because mice mutant for either BMP antagonist have only
minor defects in mandibular development, we expected at
most a subtle downregulation of Fgf8 in BA1 of single
mutants. Indeed, WMISH of Nog2/2 mice at E10.5 shows
little if any decrease in Fgf8 expression in branchial arches
relative to nonaffected littermates (Fig. 7J,K; 4:4). In con-
trast, Chd;Nog double null embryos show an incompletely
penetrant reduction in BA1 expression of Fgf8 (e.g., Fig. 7
O,P). This variability in Fgf8 expression may correspond to
the variable mandibular truncations of the complex het-
erozygotes and double null mutants. Indeed, as with the
pups showing bilaterally asymmetric defects in mandibular
skeletal development (Fig. 4G,H), in some cases, the level of
repression in a single double null mutant embryo is not
identical between the bilateral swellings of the developing
BA1 (Fig. 7O,P).
One possibility for the lack of elongation seen in mutant
BA1 is a deficit in NC cells themselves. We have observed
several different markers of NC cells at various stages in
Chd;Nog mutants (Fig. 7L,M; R.M.A. unpublished results).
We have never detected a defect in NC specification,
migration or patterning.
Branchial Arch Cell Death in Embryos Lacking
BMP Antagonist Genes
If Fgf8 signaling is decreased in Chd;Nog mutants, the
loss of this growth factor should create increased rates of
cell death and decreased rates of cell proliferation. We
examined cell death by nile blue sulfate (NBS) staining in
Chd;Nog double null and complex heterozygous mutants.
At E8.5, prior to bud outgrowth, few NBS-positive cells are
detected in the first arch of either wildtype or mutant
embryos (data not shown). Although the amount of cell
death in the core mesenchyme of the first branchial arch
remains low in wildtype embryos at E9.5 (Fig. 8A), cell
death is greatly increased in this region in double nullFIG. 4. Complex heterozgotes (Chd2/2; Nog1/2) and double null
homozygotes (Chd2/2; Nog2/2) exhibit a range of craniofacial phe-
notypes. Heads of pups (A, C, E, and G) and corresponding skulls (B,
D, F, and H) are shown, all of which are the same complex
heterozygote genotype. Phenotypes range from overtly normal (A,
B) through mild micrognathia (C, D) to almost complete agnathia
(E, F); note the rudimentary mandible in F (small arrow). In the
example shown in panels G and H, the result is a mandible which
looks normal on one side but is completely absent on the other;
note the incisor on the unaffected half of the mandible (arrowhead
in H). We also found a spectrum of more anterior truncations,
which will be described elsewhere (R. M. A., unpublished results).
Embryos homozygous null for both chordin and noggin already
show a range of phenotypes at early stages of BA1 development
(E9.5 shown here) when compared to unaffected littermates (I) fromembryos (Fig. 8B-D). Variability in the level of cell death
ll rights reserved.
465Chordin and Noggin in Mandibular OutgrowthFIG. 5. Effects of ectopic BMP4 on intact mandibular explants. As diagrammed in panel A, first branchial arches from E10.5 embryos were
removed and cultured 20–24 h (E10.5 1 1D) on culture inserts over tissue-culture medium, conditions under which the tissues thrive.
Relative endogenous domains of Fgf8 and Bmp4 in wild-type BA1 are diagrammed on one half-mandible. Results are quantified in Table
1 and illustrated in panels B-I. Beads (white asterisks in all panels) coated with recombinant BMP4 protein (B, D, E, G, H, J) or control
medium (C, F, I) are placed on BA1 explants. BMP4 beads were able to induce expression of the putative transcriptional target Msx1 (B).
Ectopic BMP4 represses the expression of Pax9 (E) and Fgf8 (H); compare expression near bead to untreated side of explant. Control beads
have none of the effects shown by BMP4 (C, F, I). Additionally, BMP4 induces the expression of its antagonists noggin (D) and chordin (G,
J). Insets in G are a closer view of the same bead (a) and a separate bead which did not induce Chd (b) showing the relatively weak signal
is not simply an effect of bead placement and perturbation of BA1 tissue. Some explants with Chd expression induced by BMP4 beads in
E10.5 explants show weak lateral expression, as in this example. Additionally, Chd induction is more robust in E11.5 explants (2:7) and
medial areas of weak expression are noted. Location of beads did not affect any induction. (Panel A adapted from Larsen, 1997).
FIG. 6. Msx1 and noggin are early responses to increased BMP4, while Fgf8 is later. Application of BMP4 protein (beads highlighted by
white asterisks in all panels) for 1 h (A, C, E) in mandibular explant culture induces Msx1 (A) and noggin (B) but doesn’t repress Fgf8 (E).
At 3 h of BMP4 co-culture, induction of Msx1 (B) and noggin (D) is more robust and Fgf8 (F) repression is now clear.
© 2001 Elsevier Science. All rights reserved.
466 Stottmann, Anderson, and Klingensmith(Fig. 8B,C) as well as asymmetric cell death (Fig. 8D) likely
result in the great variability of mandibular phenotypes in
double mutants. The pattern of cell death observed re-
sembles that observed in the absence of Fgf8 in the first
branchial arch (Trumpp et al., 1999), strongly suggesting
that the lack of this growth factor contributes to the defects
observed.
We also determined an apoptotic index and a proliferative
index using thin sections. We detected apoptosing cells in
thin sections using TUNEL analysis and simultaneously
detected cells in metaphase with an antibody directed
against phosphorylated histone (Fig. 8G,H). Apoptosing and
proliferating cells were counted in four separate fields of
first branchial arch mesenchyme in one pair of littermates.
Similar results were observed in other pairs of littermates.
Of 904 wildtype cells counted, 7.1% were in metaphase and
0.22% were TUNEL-positive. Of 911 Chd;Nog double null
cells counted, 6.5% were in metaphase, and 11.0% were
TUNEL-positive. From this, we conclude that proliferation
is essentially unchanged, and apoptosis is dramatically
increased nearly 50-fold in the mesenchyme of the first
branchial arch in Chd;Nog double null embryos.
In addition to hypoplasia of the first branchial arch, some
mutants have BA1 lobes abnormally fused at the midline.
These mutants have increased levels of NBS-positive cells
in the midline at E9.5, but not throughout the mesenchyme
TABLE 2
Effects of BMP4 on Mandibular Explants from E10.5 Embryos
Marker BMP4 BSA control
Fgf8 n 5 15 n 5 12
Repression 1 8 Repression 1 1
Repression 11 7 Repression 11 0
No effect 0 No effect 11
Pax9 n 5 4 n 5 4
Repression 1 0 Repression 1 0
Repression 11 3 Repression 11 0
No effect 1 No effect 4
n 5 7 n 5 4
Msx1 Induction 1 5
Induction 11 2
No effect 0 No effect 4
Noggin n 5 5 n 5 5
Induction 1 0
Induction 11 4
No effect 1 No effect 5
Chordin n 5 9 n 5 5
Induction 1 6
Induction 11 0
No effect 3 No effect 5
Note. Mandibular explants from E10.5 embryos were cultured
with recombinant protein treated beads for 20–24 h. Explants were
scored for repression or induction of the relevant marker. Those
displaying a change were classified as showing mild (1) or strong
(11) effects.(Fig. 8F). This alternate pattern of cell death suggests that
© 2001 Elsevier Science. Athe mechanics of this class of mutant phenotypes differs
substantially from Fgf8 mutants, and may result from an
early deletion of the midline (R.M.A., J.K., unpublished
observations).
DISCUSSION
We have determined a requirement for two dedicated
BMP antagonists, Chordin and Noggin, in normal mandib-
ular development in the mouse. Both Chd and Nog are
expressed in the mandibular prominence during patterning
and in the pharyngeal region adjacent to the initial BA1
swellings. Nog2/2 mice have modestly dysmorphic man-
dibles, whereas Chd2/2 mice have overtly normal man-
dibles. Neither appears to have a defect in tooth develop-
ment. However, Chd and Nog are functionally redundant in
promoting mandibular outgrowth, in that complex het-
erozygotes (Chd2/2;Nog1/2) and double null mutants
(Chd2/2;Nog2/2) have a spectrum of mandibular hypoplasia
culminating in almost total agnathia. Although mandibular
prominences grow in part by streaming in of neural crest
cells from the pharyngeal region, neural crest specification
and migration into BA1was normal even in strongly af-
fected Chd;Nog double mutants. We also detected no sig-
nificant decrease in proliferation of cells during outgrowth.
To determine what alternative explanation(s) might ac-
count for the mandibular truncations we observe, we used
an explant system to model the effects of excessive BMP4
on early mandibular tissue. Ectopic BMP4 induced both
Chd and Nog expression, and repressed Fgf8 expression in
the cultured explants. Double null mutants show greatly
increased levels of Nog transcription and most show a
reduction in Fgf8 expression, as does a smaller proportion of
the complex heterozygotes. We suggest that ectopic BMP
signaling in these mutants causes a downregulation of Fgf8,
which serves as a trophic factor for cells populating BA1
(Trumpp et al., 1999). Double mutants show increased cell
death during early mandibular outgrowth very similar to
that observed when Fgf8 is specifically ablated in BA1
(Trumpp et al., 1999). Ectopic BMP activity may also
TABLE 3
Ectopic BMP4 Has Rapid Effects on Targets
in Mandibular Explants
Marker 6h 3h 1h
Fgf8 (repression) 3/5 4/4 0/7
Msx1 (induction) 3/3 4/4 5/5
Noggin (induction) 2/2 3/3 3/3
Note. Explants treated with recombinant BMP4 were fixed at 1,
3, and 6 h after bead addition and assayed by whole mount in situ
hybridization for target gene expression. Data is shown as the
number of repressive or inductive events as a portion of the total
experiments.
ll rights reserved.
467Chordin and Noggin in Mandibular Outgrowthincrease apoptosis independently, in that it promotes apop-
tosis in craniofacial neural crest (Graham et al., 1996).
Thus, the BMP antagonists Chordin and Noggin are essen-
tial for mandibular development in the mouse, acting to
maintain a proper balance of signaling and trophic factors
during outgrowth.
Expression and Function of Chordin and Noggin
in the Mandibular Arch Are Redundant
The BA1 phenotypes we have observed in Chd;Nog
mutants have been apparent as early as E9.0, which is when
mandibular outgrowth begins. The mandibular buds begin
as paired swellings ventrolateral to the pharynx, and grow
as cranial NC cells migrate through the pharynx and into
the bud to form the mesenchymal core of the mandibular
prominence. During this time, Chd and Nog are both
expressed in the pharyngeal endoderm and at lower levels in
the pharyngeal ectoderm. Nog is also expressed in migrating
NC cells as they stream into the bud. Fgf8 is also expressed
in the pharyngeal endoderm and ectoderm (Crossley and
Martin, 1995), where it provides a critical trophic signal for
survival of NC cells as they migrate into the mandibular
region (Trumpp et al., 1999). The earliest defect we have
detected is marked downregulation of pharyngeal Fgf8 ex-
pression at E8.5. Because Chordin and Noggin are both
dedicated BMP antagonists, embryos carrying null alleles
presumably exhibit localized ectopic BMP activity. Our
explant experiments show that in the mouse mandibular
bud, BMP4 beads downregulate Fgf8 expression. The prob-
able increase in peripharyngeal activity of BMPs might
therefore be sufficient in some cases to downregulate Fgf8
expression and consequently lead to increased cell death of
migrating NC cells (Fig. 9). Indeed, we detected increased
cell death in the mandibular process at E9.0–9.5 in a
distribution very similar to that observed in embryos lack-
ing Fgf8 function in the pharyngeal/mandibular region
(Trumpp et al., 1999). Recent work in chick embryos
provides strong support for this model. Ectopic BMP at the
site of BA1 outgrowth results in down-regulation of Fgf8
expression and truncation of mandibular outgrowth (Shige-
tani et al., 2000).
We suggest that the variability of the mandibular hyp-
oplasia observed when Chordin and Noggin are reduced or
absent is a result of variable down-regulation of Fgf8.
Consistent with the range in mandibular truncations, we
see a range in the extent of cell death in the elongating buds.
Interestingly, these defects are sometimes asymmetric,
occasionally resulting in one normal “half-mandible” and
one side where the jaw is completely absent (Fig. 3H). This
asymmetry may be due to a stochastic difference between
the mandibular buds in BMP signaling prior to their fusion.
We have seen mutant embryos in which the expression of
Fgf8 differs between the two premandibular areas (Fig.
7O,P), and corresponding asymmetric patterns of cell death
in the nascent mandibular buds (Fig. 8D). We speculate that
such embryos would go on to have asymmetric mandibular
© 2001 Elsevier Science. Atruncations. Similarly asymmetric phenotypes are also ob-
served in certain human craniofacial syndromes (Escobar,
1993), further implying that abnormal BMP or FGF activity
might underlie some such human malformations.
Despite expression of Chd and Nog expression in the oral
epithelium, and evidence that BMP signaling must be
properly regulated for normal tooth development (Tucker et
al., 1998), none of the mutant classes reveal any overt
defects in tooth position, shape or morphology. Possible
tooth phenotypes in a Chd2/2;Nog2/2 double mutant may be
present, but can only be revealed in a tissue specific
knockout due to early lethality. Alternatively, they may
have no critical role in tooth development or their function
may be redundant with additional BMP antagonists. Mice
mutant for follistatin have tooth defects (Matzuk et al.,
1995), and Follistatin is able to antagonize BMPs as well as
other TGFb ligands (Fainsod et al., 1997; reviewed in
Harland and Gerhart, 1997). Another nonspecific BMP
antagonist, DAN, is also expressed in BA1 (Stanley et al.,
1998), but loss of DAN alone or when Nog is reduced causes
no BA1 phenotype (Dionne et al., 2001).
We also found that Nog is expressed in the neural crest
populating BA1 during outgrowth, and later in the neural-
crest derived Meckel’s cartilage at the core of the mandible.
Meckel’s cartilage becomes ensheathed by bone during
skeletogenesis, and it may be that Nog expression therein
regulates the process of ossification. This may explain the
thickened bony tissue of Nog2/2 mandibles, since loss of the
antagonist might result in local overactivity of BMP, in turn
causing excess bone production.
An Explant System Reveals Novel BMP
Interactions in Branchial Arch Tissue
To model the effects of the increase in BMP signaling
expected to occur in the absence of these BMP antagonists,
we applied beads soaked in recombinant BMP4 to cultured
E10.5 mandibular explants. We used BMP4 in our experi-
ments as a means of increasing the activation of BMP signal
transduction, but do not mean to imply that it is the only
relevant BMP in vivo. Chordin and Noggin together antago-
nize BMP4, BMP2, and BMP7 (Harland and Gerhart, 1997),
and probably other, untested BMPs as well. Other studies
have shown these BMPs to be largely interchangeable in the
context of explant and embryo manipulations, activation of
signaling pathways, and other functional assays (Massugue
and Chen, 2000; Hogan, 1996). As previously discussed,
several BMPs are expressed during early mandibular devel-
opment and have dramatic effects in BA1 manipulation
experiments (see Introduction). In vivo, BMP2, 4, and 7 are
all potentially regulated by BMP antagonists during man-
dibular development.
Ectopic BMP4 induced the expression of its own antago-
nists, Chd and Nog, as well as previously established
transcriptional targets such as Msx1. The induction of Nog
was very rapid, robust within an hour, presumably before a
round of transcription, translation and processing of an
ll rights reserved.
heads). Both the right (O) and left (P) side of a double mutant and
the right side of a wild-type (N) littermate are shown; note the more
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© 2001 Elsevier Science. Aintermediate protein could be completed. Thus, we suggest
that this induction does not depend on the prior upregula-
tion of Msx1, but rather occurs via activation of some
pre-existent regulatory mechanism. Indeed, BMP4 does not
require Msx1 (Chen et al., 1996) to induce one of its known
targets, Lef1 (Kratochwil et al., 1996) in BA1 explants.
While Nog is expressed in the oral epithelium along the
entire proximo-distal axis (Fig. 1), Bmp4 is restricted to the
most distal tissue. Other BMPs may be the endogenous
upstream signal for Nog induction in the embryo. Indeed,
Bmp7 is expressed throughout the oral epithelium in a
pattern very similar to that of Nog (Solloway and Robert-
son, 1999). This upregulation of Nog and Chd by excessive
BMP could reflect a negative feedback mechanism to keep
functional BMP levels in check, probably able to compen-
sate very quickly for excessive BMP.
A key finding of our mandibular explant experiments is
that BMP4 beads repressed Fgf8 expression. In many devel-
opmental contexts BMPs and FGFs have antagonistic inter-
actions; some of these may be due to a direct repression of
Fgf expression by BMP. There is some precedent for this:
ectopic BMP4 represses Fgf4 expression in the chicken
feather bud (Jung et al., 1998), and may do so in limb bud
formation (Pizette and Niswander, 1999). Consistent with
our results, ectopic BMP beads applied to chick pharyngeal
ectoderm downregulated Fgf8 in vivo (Shigetani et al.,
2000). Fgf8 and Bmp4 may have slightly overlapping do-
mains of expression in the oral epithelium. We suggest that
Fgf8 expression is protected from the effects of BMP4 by the
presence of BMP antagonist such as Noggin and Chordin.
Expression of BA1 Markers in Mice Mutant
for BMP Antagonists
To test some of the hypotheses generated by the mandib-
ular explant work, we looked at the expression patterns of
BA1 markers in mice mutant for the BMP antagonists.
Since we found that BMP upregulates its antagonists in
explants, we assessed Nog expression in Nog2/2 mutants
using both the lacZ transgene and WMISH. We find that
Nog is indeed expressed more highly at both E9.5 and E10.5
in all domains observed, including BA1. This upregulation
was much stronger in embryos lacking both Chd and Nog,
in which case there is presumably a higher level of ectopic
BMP activity. Upregulation of Nog transcription by ectopic
BMP has been demonstrated previously both in cell culture
(Gazzerro et al., 1998; Kameda et al., 1999; Nifuji and Noda,
1999) and in the chick digit (Merino et al., 1998). Interest-
ingly, BMP induction of Nog in the BA1 explants occurs
severe reduction in P. Black markings in N, P indicate direction of
heart looping. Looping is to the right in N and to the left in P,
reflecting abnormalities in left-right patterning seen in the doubleFIG. 7. Analysis of branchial arch markers in chordin and noggin
mutants. Nog-lacZ is broadly upregulated in Nog2/2 embryos (B)
when compared to heterozygous littermates (A) at E10.5. This is
even more pronounced in the Chd2/2;Nog2/2 double mutant (C;
shown at E11.5). Nog-lacZ upregulation is also present in the first
branchial arches; compare Nog1/2 (D) to Nog2/2 (E). Increased
Nog-lacZ expression correlates with increased noggin expression
in WMISH at E9.5 (compare F, G). Panels H-K show isolated BA1
from E10.5 embryos from the ventral aspect. Bmp4 expression is
more intense in Nog2/2 mutants (H) compared to wild-type (WT)
littermates (I). Fgf8, however, does not seem to be different between
Nog2/2 (J) and wild-type embryos (K). AP2a expression indicates
neural crest does properly migrate to BA1 in both wild-type (L) and
mutant (M) embryos. Analysis of Chd2/2;Nog2/2 double null mu-
tant embryos at E8.5 sometimes reveals an asymmetric decrease in
BA1 Fgf8 expression (O, P; BA1 domain indicated by white arrow-mutants (Bachiller et al., 2000). fb, forebrain; he, heart.
ll rights reserved.
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469Chordin and Noggin in Mandibular Outgrowthmuch faster than that observed in the chicken digit (Merino
et al., 1998). We also observed an increase in BMP4 tran-
scription in the branchial arches of Nog2/2 embryos, further
suggesting that the molecular feedback circuitry governing
net BMP4 activity is complex.
While ectopic BMP4 can repress Fgf8 in mandibular
explants, Fgf8 is only mildly repressed if at all in BA1 of
Nog2/2 embryos. However, in Chd2/2;Nog2/2 embryos, Fgf8
is frequently severely reduced or absent in the branchial
arches. Less frequently, similar Fgf8 downregulation was
observed in the complex heterozygote. These data suggest
that the BMP antagonists function redundantly in vivo to
limit the repressive effect of Bmp4 on Fgf8 expression,
consistent with the spatiotemporal expression patterns of
Bmp4, Fgf8, and Nog during early BA1 development.
Although we find some evidence of increased BMP activ-
ity in Nog and Chd;Nog mutants, we have found no
evidence for upregulation of the BMP target Msx1 in ante-
FIG. 8. Analysis of cell death and cell proliferation in Chd: Nog d
(C) in the core mesenchyme of first branchial arches in Chd; No
littermate (A). The increase in apoptotic cells may be unilateral in
fused at the midline display marked increase in cell death at the m
wildtype littermate (E). TUNEL analysis of tissue sections reveals
embryos (H, green) relative to wildtype (G). Cell proliferation is es
FIG. 9. Model for early patterning of the mandibular prominence
the mesenchyme of BA1 (A). In wild-type embryos (B), NC cells rece
sources. BMPs are antagonized by Chd and Nog and apoptosis occu
is greatly increased. The resulting decrease in FGF ligands leads to grior tissues of any of the mutant classes (data not shown;
© 2001 Elsevier Science. AR.M.A., unpublished results). This further suggests that, in
vivo, at least some effects of increased BMP activity on
early BA1 outgrowth are not mediated by increased tran-
scription of Msx1. However, BMP7 does not efficiently
increase Msx1 expression (Furuta et al., 1997) and based on
expression is perhaps the best candidate for the endogenous
BMP effecting Fgf8 regulation in the outgrowth stage.
Integrating Chordin, Noggin, BMPs, and Fgf8
in Mandibular Outgrowth
Our observations allow us to add to the current view of
branchial arch outgrowth and patterning. Fgf8 is required
for NC survival during population of BA1 (Trumpp et al.,
1999) and BMPs can prevent outgrowth (Shigetani et al.,
2000; see above). We suggest that, in vivo, BMPs in the oral
epithelium of BA1 and Fgf8 in the pharyngeal endoderm and
BA1 oral epithelium send two competing signals to the NC
e mutants. Cell death may be mildly (B) or dramatically increased
ble null embryos (B, C; arrows) at E9.5. Compare with wildtype
(D). Mutant embryos with first branchial arch lobes abnormally
e, but not throughout the mesenchyme (F, arrows). Compare with
pproximately 50-fold increase in cell death in BA1 of double null
ially unchanged (G, H; red).
A1. NC cells migrate through the pharynx en route to populating
ophic FGF signals and apoptotic BMP signals from several different
low levels. In Chd;Nog mutants (C), BMP signaling in the pharynx
y heightened apoptosis in NC cells and defects in BA1 outgrowth.oubl
g dou
BA1
idlin
an a
sent
of B
ive tr
rs atpopulating BA1 during outgrowth (Fig. 9A): an apoptotic
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470 Stottmann, Anderson, and KlingensmithBMP signal and a trophic FGF signal. The BMP signal is
partially negated by Noggin and Chordin from the pharyn-
geal ectoderm and endoderm, and perhaps by Noggin alone
from the migrating NC, to help provide a suitable environ-
ment for NC survival (Fig. 9B). However, in the absence of
these two BMP antagonists (Fig. 9C), increased BMP activ-
ity leads to decreased Fgf8 expression, both decreasing the
survival signal mediated by Fgf8 (Trumpp et al., 1999) and
perhaps increasing the apoptosis promoted by BMP4 (Gra-
ham et al., 1996). The net result is an incomplete and
variably penetrant ablation of NC fated to populate BA1.
Although we hypothesize that the outgrowth defects we
observe in Chd;Nog mutants results in large part from Fgf8
downregulation, there is an additional defect resulting from
the loss of these BMP antagonists relative to the ablation of
Fgf8 in BA1. When Chordin and Noggin are decreased, the
mandibular hypoplasia includes a loss of distal elements.
Absence of Fgf8 results in a similar phenotype except that
distal elements persist (Trumpp et al., 1999). Because Bmp4
is expressed in this distal tissue (Jones et al., 1991; Neu-
buser et al., 1997) and because excessive BMP4 promotes
apoptosis in several contexts (e.g., Graham et al., 1996;
Gomes and Kessler, 2001; Trousse et al., 2001), it may die if
too much BMP4 is produced. Such might be expected in
Chd;Nog mutants, since they have much decreased levels
of BMP antagonism. Indeed, we detected a high level of
ectopic apoptosis in this region in the double mutants (Fig.
8E,F). There seems to be a critical period for BMP regulation
of NC survival as BMP added to later stages of chick
development result in skeletal malformations, not cell
death (Shigetani et al., 2000). We suggest this reflects a
difference in regulation of the initial outgrowth stage of
BA1 development and later patterning events, though simi-
lar regulatory factors may be involved.
BMP Signaling Is Sensitive to Dosage in Several
Developmental Contexts
The only known role of the Chordin and Noggin proteins
is to antagonize BMP and BMP-like proteins such that they
cannot bind and activate their receptors (reviewed by Sasai
and De Robertis, 1997). Known targets include BMP2 and 4
for Chordin (Piccolo et al., 1996), and BMP2,4, and 7
(Zimmermann et al., 1996), GDF6 (a.k.a. BMP13; Chang
and Hemmati-Brivanlou, 1999) and GDF5, another BMP
relative, (Merino et al., 1999) for Noggin. Given our obser-
vation that BMP can upregulate Chd and Nog in BA1, it
may upregulate other BMP antagonists as well. We have
noted previously that BMP levels are subject to several
levels of feedback regulation. Phenotypes would result only
when the total level of BMP antagonism falls below some
threshold, and some deleterious event such as Fgf8 repres-
sion occurs. As discussed earlier, the asymmetric pheno-
types we observe suggest that even within a single embryo,
BMP levels can differ significantly between the two man-
dibular prominences.These findings suggest that BMP signal transduction is
© 2001 Elsevier Science. Avery tightly regulated, with small changes in signal trans-
duction potentially resulting in dramatically different phys-
iological outcomes. In addition to the variable mandibular
phenotypes we observe here among mice of the same
genotype and genetic background, other developmental
models show high sensitivity to BMP dosage. Mice het-
erozygous for Bmp4 on a C57Bl/6 background have an
incompletely penetrant craniofacial phenotype, although
the affected tissues are not derived from BA1 (Dunn et al.,
1997). Mice heterozygous for the short-ear (Bmp5) mutation
have a skeletal phenotype (Green, 1968; Kingsley et al.,
1992). Dosage effects of Dlx homeobox genes, a target of
BMP signaling (Luo et al., 2001) have also been demon-
strated in craniofacial development (Depew et al., 1999).
Similarly, Drosophila embryos lacking one copy of the
Bmp4 homologue, decapentaplegic, show a defect in
dorsal–ventral patterning in the absence of maternal prod-
uct (Irish and Gelbart, 1987). This type of balance would
certainly be well served by a system where the active agent
(BMP) engages in a functional negative feedback loop by
inducing the expression of directly antagonistic molecules
(Noggin and Chordin). All of these findings support the
hypothesis that tightly regulated BMP activity is very
important for proper embryonic development, including
mandibular outgrowth.
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